Ofatumumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ofatumumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about SaveRxCanada.to
List of countries where we can ship Ofatumumab:
Latest news releases on Ofatumumab:
Ofatumumab is a human monoclonal antibody which targets an epitope in the CD20 molecule encompassing parts of the small and large extracellular loops.
Product details for Arzerra; Name: Arzerra: Agency product number: EMEA/H/C/001131: Active substance: ofatumumab. International non-proprietary name (INN) or common name
Drug information on Arzerra (ofatumumab), includes drug pictures, side effects, drug interactions, directions for use, symptoms of overdose, and what to avoid.
Discover ARZERRA® (ofatumumab), approved for 4 CLL treatment indications. Find dosing information & patient resources. See Important Safety Information & BOXED WARNING.
A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III
Background In patients with chronic lymphoid leukemia (CLL) or small lymphocytic lymphoma (SLL), a short duration of response to therapy or adverse cytogenetic ...
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund ...
Arzerra 100mg & 1000mg concentrate for solution for infusion - Summary of Product Characteristics (SPC) by Novartis Pharmaceuticals UK Ltd
Cases of the steroid-resistant nephrotic syndrome that are resistant to rituximab can be difficult to treat. In this report, ofatumumab, an anti-CD20 monoclonal ...
新着一覧へ ニュース. 2014/6/5. 再発性/難治性CLL患者に対するibrutinib単剤投与はofatumumabに比べ有意な生存利益をもたらす ...